Evidence map›Paper›PMID 41783253›Full record

ReviewFrontiers in dementia2026

Dementia and hearing loss: from risk to mechanisms and management.

Emma E Broome, Sian Calvert, Eithne Heffernan, Helen Henshaw, Aaliyah Khan, Vassilis Pelekanos, Joseph Sollini, Jack Stancel-Lewis, Tom Dening

Abstract readReview
In one paragraph

Review in Frontiers in dementia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Emma E BroomeNational Institute for Health and Care Research (NIHR), Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Sian CalvertNational Institute for Health and Care Research (NIHR), Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Eithne HeffernanSchool of Sport, Exercise & Health Sciences, Loughborough University, Loughborough, United Kingdom.
Helen HenshawNational Institute for Health and Care Research (NIHR), Nottingham Biomedical Research Centre, Nottingham, United Kingdom.
Aaliyah KhanSchool of Medicine, University of Nottingham, Nottingham, United Kingdom.
Vassilis PelekanosMental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Joseph SolliniMental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.
Jack Stancel-LewisNottingham University Business School, University of Nottingham, Nottingham, United Kingdom.
Tom DeningMental Health and Clinical Neurosciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hearing loss in midlife is an important and potentially modifiable risk factor for the development of dementia. Research examining the association between dementia and hearing loss has expanded rapidly; however, evidence for the mechanisms linking the two conditions is inconclusive, limiting the development of targeted interventions. This review provides a critical overview of current evidence on dementia risk in relation to hearing loss, proposed mechanisms underpinning this association, and emerging evidence on the effectiveness of hearing interventions in modifying trajectories of cognitive decline, dementia risk, and disease progression. Alongside its role as a risk factor, hearing loss commonly co-occurs with dementia, highlighting the need for integrated approaches to care that address the considerable impact of these co-morbid conditions on individuals and communities. Finally, we emphasise the importance of including diverse populations in future research to improve generalisability of findings and help advance equity in dementia prevention and care.

Indexed as

cognitive impairmentdementiahearing lossmechanismspresbycusis

Identifiers

PMID41783253
PMCPMC12953099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.